Tentt

Eli Lilly to Acquire Centessa Pharmaceuticals

Announced
HealthcareMerger

Deal Overview

Eli Lilly agreed to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders. The transaction is described as a merger and framed as an expansion into sleep medicine.

Centessa Pharmaceuticals is the target company in the deal, and the buyer is Eli Lilly. The excerpt provides the strategic focus on sleep-wake disorder therapeutics but does not include financial terms.

Key Details

Transaction
Eli Lilly acquires Centessa Pharmaceuticals
Deal Size
Over $100M

Filed under

Source

Read full article on prnewswire.com

via GN - entered into definitive agreement · March 31, 2026

Powered by Tentt

Source healthcare deals for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call

Related Deals

See all Healthcare deals →